CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-09-12 | HOLLER FRANK A Director | Exercise or conversion · Stock Option (Right to Buy) | −25,720 | 0 | ||
| 2019-09-12 | ROBIN SHERRINGTON EVP, Strategy & Innovation | Exercise or conversion | +6,172 | $3.07 | $19K | 12,064 |
| 2019-09-12 | ROBIN SHERRINGTON EVP, Strategy & Innovation | Shares withheld for taxes | −1,868 | $9.38 | $18K | 10,196 |
| 2019-09-12 | ROBIN SHERRINGTON EVP, Strategy & Innovation | Exercise or conversion · Stock Option (Right to Buy) | −6,172 | 0 | ||
| 2019-05-21 | TARNOW MICHAEL M Director | Exercise or conversion | +2,057 | $3.21 | $7K | 64,569 |
| 2019-05-21 | TARNOW MICHAEL M Director | Exercise or conversion · Stock Option (Right to Buy) | −2,057 | 0 | ||
| 2019-03-19 | Hayden Michael R Director | Exercise or conversion | +20,576 | $3.38 | $70K | 50,924 |
| 2019-03-19 | Hayden Michael R Director | Exercise or conversion · Stock Option (Right to Buy) | −20,576 | 0 | ||
| 2019-03-11 | Hayden Michael R Director | Gift | −24,045 | 107,562 | ||
| 2019-03-11 | Hayden Michael R Director | Gift | +17,337 | 114,403 | ||
| 2018-12-21 | TARNOW MICHAEL M Director | Gift | −5,000 | 62,512 | ||
| 2018-12-14 | PATOU GARY Director | Exercise or conversion | +2,057 | $3.07 | $6K | 19,459 |
| 2018-12-14 | PATOU GARY Director | Exercise or conversion · Stock Option (Right to Buy) | −2,057 | 0 | ||
| 2018-12-11 | COHEN CHARLES J. VP, Biology | Exercise or conversion | +4,115 | $3.07 | $13K | 8,194 |
| 2018-12-11 | COHEN CHARLES J. VP, Biology | Shares withheld for taxes | −1,644 | $7.00 | $12K | 6,550 |
| 2018-12-11 | COHEN CHARLES J. VP, Biology | Exercise or conversion · Stock Option (Right to Buy) | −4,115 | 0 | ||
| 2018-12-06 | AZAB MOHAMMAD Director | Exercise or conversion | +3,086 | $3.07 | $9K | 57,584 |
| 2018-12-06 | AZAB MOHAMMAD Director | Exercise or conversion · Stock Option (Right to Buy) | −3,086 | 0 | ||
| 2018-06-21 | TARNOW MICHAEL M Director | Exercise or conversion | +5,144 | $3.70 | $19K | 60,311 |
| 2018-06-21 | TARNOW MICHAEL M Director | Exercise or conversion | +2,057 | $3.66 | $8K | 62,368 |
Page 26 of 27 · 536 trades